i-Optics finds funds to globally launch eye diagnostic products

Nieuws -

i-Optics, a pioneer in eye diagnostic solutions, secured EUR 13.7 million equity from existing and new investors, among which NIBC. With this new injection of capital, i-Optics will accelerate the launch of Cassini, a diagnostic solution for cataract surgery procedures. It further allows the company to expand the market introduction of the EasyScan eye diagnosis solution with Japanese multinational HOYA.
 
NIBC participated in this equity round together with existing investors VC funds Aescap Venture, HBM Partners, family fund De Hoge Dennen, as well as i-Optics management. New equity investors were the HealthCrest Group and IPF Partners. NIBC will play an active supportive role in the company, together with the other investors which include our NIBC clients; De Hoge Dennen and Aescap.

Like deze pagina op
Bel me terug
Vul alstublieft uw naam in Onderwerp is verplicht Vul alstublieft uw telefoonnummer in